Non-Cutaneous Melanoma — Trials

Non-Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

312 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 87
Recruiting: 44
Ph III recruiting: 6
Growth YoY: —
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 301–312 of 312 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00110123	Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma	terminated	Phase 3	171	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	4	Sep 24, 2012	clinicaltrials
NCT00750399	Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma	completed	Phase 1	10	The New York Eye Cancer CenterOTHER	1	Apr 26, 2012